About
Profile
Sarepta Therapeutics is a U.S. commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare neuromuscular diseases.
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
SRPT
Recent Earnings
Sarepta Therapeutics GAAP EPS of -$0.46 beats by $0.80, revenue of $331.8M beats by $45.03M
The bio-pharmaceutical stock advanced 1.6% after notably outperforming Wall Street expectations in the third quarter. Sarepta said it lost 46 cents per share and saw a revenue of $331.8 million. Meanwhile, Analysts anticipated a much larger loss of $1.22 per share on revenue of $285.3 million.
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Sarepta Therapeutics GAAP EPS of -$0.46 beats by $0.80, revenue of $331.8M beats by $45.03M
- Sarepta Therapeutics Q3 2023 Earnings Preview
- Biggest stock movers today: Caterpillar, Arista Networks, BP, Pinterest and more
- Sarepta in selloff after late-stage setback for Duchenne candidate
- 5 stocks to watch on Tuesday: Sarepta Therapeutics, Pfizer, AMD and more
- Sarepta Phase 3 study for DMD drug fails to meet primary endpoint
- Mizuho doesn't see Sarepta price decline connected to EMBARK study
- Sarepta Therapeutics Non-GAAP EPS of -$0.85 beats by $0.15, revenue of $261.2M beats by $5.36M
- Sarepta Therapeutics Q2 2023 Earnings Preview
- Acumen, BridgeBio, Arcus among BTIG's top healthcare picks for 2H 2023
- Catalyst Watch: CPI, major bank earnings, Amazon Prime Day and CAVA ratings
- Sarepta raises $102M from selling priority review voucher
- Sarepta down 9% as Duchenne treatment gets narrow population approval
- Sarepta Duchenne treatment wins FDA nod, but with smaller population (update)
- Regenxbio, UPenn file second patent suit against Sarepta over DMD therapy
- Catalyst watch: C3.ai and Salesforce earnings, Knife River debut, Kenvue ratings & Faraday Future event
- Hot Stocks: ANF, URBN and PANW rise on earnings; A, XPEV fall on weak outlooks; OCGN slides
- Sarepta says FDA needs more time to review muscular dystrophy drug
- Billions of dollars at stake as FDA shortcut allows half-proven drugs - report
- Argenx, Blueprint Medicines, Sarepta likely M&A targets - analyst
Recent Earnings
Sarepta Therapeutics GAAP EPS of -$0.46 beats by $0.80, revenue of $331.8M beats by $45.03M
Earnings History
| Date | EPS / Forecast | Revenue / Forecast | |
|---|---|---|---|
| October 27, 2021 | - / -1.83 | - / 171.36M | |
| August 4, 2021 | -1.02 / -1.3 | 164.09M / 167.07M | |
| May 5, 2021 | -2.1 / -1.83 | 146.93M / 145.81M |
Beat! |
| March 1, 2021 | -2.4 / -1.8 | 145.14M / 150.38M | |
| November 5, 2020 | -2.5 / -1.71 | 143.92M / 137.76M |
Beat! |
| August 5, 2020 | -1.93 / -1.72 | 137.36M / 116.29M |
Beat! |
| May 6, 2020 | -0.23 / -1.92 | 113.67M / 116.49M | |
| February 26, 2020 | -3.16 / -1.81 | 100.11M / 98.8M |
Beat! |
| November 7, 2019 | -1.7 / -1.35 | 99.04M / 98.48M |
Beat! |
| August 7, 2019 | -3.74 / -1.07 | 94.67M / 91.05M |
Beat! |
| May 8, 2019 | -1.07 / -1.61 | 87.01M / 86.6M |
Beat! |
| February 27, 2019 | -2.05 / -1.02 | 84.42M / 84.92M | |
| October 24, 2018 | -1.15 / -0.78 | 78.49M / 78.75M | |
| August 8, 2018 | -1.67 / -0.84 | 73.53M / 71.4M |
Beat! |
| May 3, 2018 | -0.55 / -0.32 | 64.6M / 65.09M | |
| February 26, 2018 | - / -0.32 | - / 55.57M | |
| October 25, 2017 | -0.76 / -0.85 | 45.95M / 40.77M |
Beat! |
| July 19, 2017 | -0.46 / -0.77 | 35.01M / 22.38M |
Beat! |
| April 27, 2017 | -0.71 / -0.81 | 16.34M / - |
Beat! |
| February 28, 2017 | -0.71 / -0.45 | 5.42M / 46.83M | |
| October 27, 2016 | -1.18 / -0.52 | - / 3.08M |
| Date | Price | Open | High | Low | Vol | Change | |||
|---|---|---|---|---|---|---|---|---|---|
| Dec 4 | 86.12 | 84.38 |
86.94
|
84
|
1.3M | 1.99% | |||
| Dec 1 | 84.44 | 81.28 |
84.5
|
78.67
|
1.3M | 3.89% | |||
| Nov 30 | 81.28 | 81.01 |
81.9
|
80.22
|
1.3M | 1.09% | |||
| Nov 29 | 80.4 | 82.72 |
83.5
|
80.14
|
1.1M | -2.68% | |||
| Nov 28 | 82.61 | 81.97 |
82.9
|
81.6
|
928K | 0.04% | |||
| Nov 27 | 82.58 | 82.5 |
84.04
|
81.64
|
651K | -0.35% | |||
| Nov 24 | 82.87 | 83.83 |
84.23
|
82.28
|
395K | -1.07% | |||
| Nov 22 | 83.77 | 84.42 |
85.23
|
82.06
|
607K | -0.37% | |||
| Nov 21 | 84.08 | 85.03 |
85.4
|
83.42
|
1.0M | 1.23% | |||
| Nov 20 | 83.06 | 83 |
85.94
|
82.62
|
1.4M | -0.11% | |||
| Nov 17 | 83.15 | 82.98 |
85.5
|
82.77
|
1.4M | 0.20% | |||
| Nov 16 | 82.98 | 83.08 |
83.43
|
81.18
|
1.4M | -0.93% | |||
| Nov 15 | 83.76 | 81.77 |
84.71
|
81.46
|
1.2M | 1.53% | |||
| Nov 14 | 82.5 | 81.93 |
82.56
|
80.68
|
1.7M | 3.55% | |||
| Nov 13 | 79.67 | 79.74 |
80.3
|
76.61
|
883K | 0.28% | |||
| Nov 10 | 79.45 | 78.81 |
79.66
|
76.25
|
1.3M | 0.38% | |||
| Nov 9 | 79.15 | 79.88 |
80.25
|
75.85
|
2.1M | -1.91% | |||
| Nov 8 | 80.69 | 82.93 |
83.47
|
80.4
|
1.1M | -2.7% | |||
| Nov 7 | 82.93 | 80.62 |
84.19
|
80.62
|
2.2M | 3.53% | |||
| Nov 6 | 80.1 | 81.5 |
83.11
|
79.66
|
2.6M | 2.68% | |||
| Nov 3 | 78.01 | 78.42 |
81.27
|
77.8
|
2.3M | 0.32% | |||
| Nov 2 | 77.76 | 79.43 |
82.22
|
75.69
|
3.7M | 1.62% | |||
| Nov 1 | 76.52 | 68.4 |
76.77
|
68
|
6.8M | 13.68% | |||
| Oct 31 | 67.31 | 57.63 |
68
|
55.25
|
23.5M | -37.47% | |||
| Oct 30 | 107.65 | 107.95 |
109.96
|
106.92
|
742K | 0.77% | |||
| Oct 27 | 106.83 | 111.9 |
111.9
|
106.05
|
929K | -4.27% | |||
| Oct 26 | 111.6 | 107.39 |
112.23
|
105.92
|
1.1M | 4.07% | |||
| Oct 25 | 107.24 | 112.39 |
112.66
|
106.52
|
1.1M | -5.45% | |||
| Oct 24 | 113.42 | 111.63 |
113.95
|
110.72
|
827K | 1.81% | |||
| Oct 23 | 111.4 | 111 |
113.42
|
109.78
|
869K | 0.18% | |||
| Oct 20 | 111.2 | 113.18 |
113.96
|
111
|
1.0M | -1.59% | |||
| Oct 19 | 113 | 114.55 |
114.99
|
111.78
|
743K | -0.72% | |||
| Oct 18 | 113.82 | 118.32 |
118.32
|
112.77
|
938K | -4.07% | |||
| Oct 17 | 118.65 | 117 |
119.99
|
116.57
|
710K | 0.94% | |||
| Oct 16 | 117.55 | 117.75 |
119.06
|
116.44
|
651K | -0.35% | |||
| Oct 13 | 117.96 | 116.7 |
118.73
|
114.12
|
780K | 0.64% | |||
| Oct 12 | 117.21 | 125 |
125
|
116.82
|
1.1M | -6.05% | |||
| Oct 11 | 124.76 | 122.9 |
124.85
|
122.4
|
782K | 1.55% | |||
| Oct 10 | 122.86 | 123.4 |
124.01
|
121.5
|
1.4M | -0.46% | |||
| Oct 9 | 123.43 | 122.97 |
124.1
|
121.12
|
1.0M | -0.41% | |||
| Oct 6 | 123.94 | 120.79 |
124.16
|
119.85
|
879K | 2.08% | |||
| Oct 5 | 121.41 | 117.89 |
122.65
|
117
|
1.1M | 3.06% | |||
| Oct 4 | 117.81 | 119.99 |
120.63
|
116.82
|
1.3M | -2.19% | |||
| Oct 3 | 120.45 | 117.97 |
121.07
|
117.71
|
916K | 1.57% | |||
| Oct 2 | 118.59 | 120.4 |
121.67
|
118.09
|
917K | -2.17% | |||
| Sep 29 | 121.22 | 124 |
124.1
|
120.84
|
782K | -1.92% | |||
| Sep 28 | 123.59 | 122.94 |
124.51
|
121.31
|
937K | 0.12% | |||
| Sep 27 | 123.44 | 120.52 |
124.15
|
119.34
|
858K | 3.37% | |||
| Sep 26 | 119.41 | 114.92 |
119.94
|
114.92
|
805K | 4.07% | |||
| Sep 25 | 114.74 | 120 |
120.3
|
110.56
|
1.7M | -4.33% | |||
| Sep 22 | 119.93 | 120 |
121.82
|
119.65
|
553K | 0.32% | |||
| Sep 21 | 119.55 | 117.32 |
119.79
|
117.27
|
828K | 1.34% | |||
| Sep 20 | 117.97 | 118.85 |
118.85
|
117.41
|
721K | -0.96% | |||
| Sep 19 | 119.11 | 118.66 |
120.11
|
118.1
|
727K | 0.90% | |||
| Sep 18 | 118.05 | 117.79 |
118.65
|
116.98
|
705K | -0.3% | |||
| Sep 15 | 118.4 | 119.4 |
120.05
|
117.4
|
1.0M | -1.1% | |||
| Sep 14 | 119.72 | 119.47 |
120.48
|
119
|
629K | 0.62% | |||
| Sep 13 | 118.98 | 119.69 |
120.53
|
118.03
|
536K | -0.73% | |||
| Sep 12 | 119.85 | 118.03 |
120.79
|
117.88
|
642K | 1.22% | |||
| Sep 11 | 118.4 | 120.05 |
120.63
|
118.22
|
801K | 0% | |||